Literature DB >> 16141677

The role of the thymus in the pathogenesis of myasthenia gravis.

Hiroshi Onodera1.   

Abstract

Myasthenia gravis is an organ-specific autoimmune disease characterized by the production of anti-acetylcholine receptor antibodies. In this review, I describe the pathophysiological importance of the altered chemokine receptor-mediated signaling in the thymus and peripheral blood of myasthenia gravis patients. The epidemiological and clinical features of myasthenia gravis are also discussed.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16141677     DOI： 10.1620/tjem.207.87

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN： 0040-8727            Impact factor:   1.848


  5 in total

1.  High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients.

Authors:  Yongxiang Yang; Min Zhang; Yuqin Ye; Shan Ma; Lingling Fan; Zhuyi Li
Journal:  Neurol Sci       Date:  2017-06-03       Impact factor: 3.307

2.  Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.

Authors:  Natalie Tsinzerling; Ann-Kari Lefvert; Georg Matell; Ritva Pirskanen-Matell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-12       Impact factor: 10.154

3.  Magnetic resonance imaging characteristics of thymoma in Vietnamese patients with myasthenia gravis in relation to histopathological type and disease staging.

Authors:  Phung Anh Tuan; Nguyen Minh Duc
Journal:  Contemp Oncol (Pozn)       Date:  2020-09-17

4.  Expression of immune molecules CD25 and CXCL13 correlated with clinical severity of myasthenia gravis.

Authors:  Min Zhang; Jun Guo; Hongzeng Li; Yongan Zhou; Feng Tian; Li Gong; Xianni Wang; Zhuyi Li; Wei Zhang
Journal:  J Mol Neurosci       Date:  2013-02-10       Impact factor: 3.444

5.  A Thymic Hyperplasia Case without Suppressing on Chemical Shift Magnetic Resonance Imaging.

Authors:  Tuan Phung; Thach Nguyen; Dung Tran; Nga Phan; Hung Nguyen
Journal:  Case Rep Radiol       Date:  2018-05-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.